Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Aeglea BioTherapeutics, Inc. (AGLE)

Pharmaceutical Preparations

https://www.aegleabio.com

Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company developing human enzyme therapeutics to benefit people with rare metabolic diseases. The company competes in the segments of the pharmaceutical, biotechnology and other related markets that address rare genetic diseases.

221 CRESCENT STREET, BUILDING 23, SUITE 105
WALTHAM, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/07/2016

Market Cap

48,627,649

Shares Outstanding

4,050,000

Weighted SO

4,048,927

Total Employees

N/A

Upcoming Earnings

03/07/2024

Beta

2.5720

Last Div

0.0000

Range

2.66-24.0

Chg

0.7500

Avg Vol

59537

Mkt Cap

48627649

Exch

NASDAQ

Country

US

Phone

512 942 2935

DCF Diff

3.6207

DCF

8.3893

Div Yield

0.0000

P/S

46.1363

EV Multiple

-0.4014

P/FV

-0.2101

Div Yield %

0.0000

P/E

-0.1751

PEG

-0.2739

Payout

0.0000

Current Ratio

4.5897

Quick Ratio

4.5410

Cash Ratio

2.0189

DSO

56.4469

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

1.0000

Op Margin

-204.5076

Pretax Margin

-279.3359

Net Margin

-279.3472

Eff Tax Rate

0.0000

ROA

-1.4206

ROE

3.1933

ROCE

-1.3273

NI/EBT

1.0000

EBT/EBIT

1.3659

EBIT/Rev

-204.5076

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

21555.1000

CF/Debt

0.0000

Equity Multi

-0.8446

Rec Turnover

6.4663

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0051

OCF/Share

-20.2650

FCF/Share

-20.2650

Cash/Share

47.4168

OCF/Sales

-82.5560

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-0.2101

P/B

-0.2101

P/S

46.1363

P/E

-0.1751

P/FCF

-0.5588

P/OCF

-0.5926

P/CF

-0.5926

PEG

-0.2739

P/S

46.1363

EV Multiple

-0.4014

P/FV

-0.2101

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation